磷酸西格列汀联合二甲双胍治疗2型糖尿病临床疗效探究

The Clinical Efficacy of Sitagliptin Phosphate Combined with Metformin in the Treatment of Type 2 Diabetes

目的研究分析磷酸西格列汀联合二甲双胍治疗2型糖尿病临床疗效。方法对86例于2018年10月—2019年10月入院就诊2型糖尿病患者进行该次研究,通过随机分组,将患者平均分成常规组和联合组两组,每组43例患者。常规组患者使用二甲双胍进行治疗,联合组患者采用磷酸西格列汀联合二甲双胍进行治疗,治疗实施后,对比两组患者数据评分结果。结果治疗后,联合组患者临床治疗效果、治疗成效、用药反应、2型糖尿病疾病控制有效率等均优于常规组患者,差异有统计学意义(P<0.05)。结论对2型糖尿病患者使用磷酸西格列汀联合二甲双胍进行治疗,可以有效控制患者血糖水平,提高临床治疗效果,对2型糖尿病具有显著的临床应用价值。

Objective To study and analyze the clinical efficacy of sitagliptin phosphate combined with metformin in the treatment of type 2 diabetes.Methods This study was conducted on 86 patients with type 2 diabetes who were admitted to the hospital from October 2018 to October 2019.Through random grouping,the patients were divided into two groups,the conventional group and the combined group,with 43 patients in each group.Patients in the routine group were treated with metformin,and patients in the combination group were treated with sitagliptin phosphate combined with metformin.After the treatment was implemented,the data score results of the two groups were compared.Results After treatment,the clinical treatment effect,treatment effect,medication response,effective rate of type 2 diabetes control in the combined group were better than those in the conventional group,the difference was statistically significant(P<0.05).Conclusion The use of sitagliptin phosphate combined with metformin for treatment of type 2 diabetes patients can effectively control the patient's blood glucose level,improve the clinical treatment effect,and have significant clinical application value for type 2 diabetes.